Joshua Pinto
Director, President & CEO; President · 2 filings · Latest: Aug 20, 2026
Neumora Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
NMRA | Joshua Pinto | President | Feb 17, 2026 | Sale | $3.54 | 5,967 | $21.1K | 57,783 | |
NMRA | Pinto Joshua | — | Feb 17, 2026 | Proposed Sale | $3.54 | 5,967 | $21.1K | — | |
NMRA | Pinto Joshua | — | Feb 18, 2025 | Proposed Sale | $1.67 | 8,048 | $13.5K | — | |
NMRA | Pinto Joshua | — | Aug 22, 2024 | Proposed Sale | $11.90 | 100,000 | $1.2M | — |